NEXN insider files Form 144 to sell 483,750 shares valued at $4.92M

Rhea-AI Filing Summary

Nexxen International Ltd. filed a Form 144 notifying the proposed sale of 483,750 ordinary shares on or about 08/25/2025 through Oppenheimer & Co. Inc. at an aggregate market value of $4,919,737.50. The filing lists the seller's historical acquisitions as restricted stock units and founder/RSU awards dated between 01/01/2020 and 12/20/2024, totaling the lots disclosed in the table. The issuer has 65,562,670 shares outstanding, implying the proposed sale represents a small fraction of total shares. The notice also discloses a prior sale of 410,000 shares on 07/01/2025 for gross proceeds of $4,164,685.56. The filer certifies no undisclosed material adverse information and complies with Rule 144 disclosure requirements.

Insights

Securities Analyst

TL;DR: Routine Rule 144 insider sale disclosure; size is modest relative to outstanding shares and likely neutral for valuation.

The filing notifies a planned sale of 483,750 ordinary shares valued at $4.92 million and references multiple prior RSU/founder-share grants dating from 2020–2024. Against 65.56 million shares outstanding, the planned sale represents under 1% of the issued share count, indicating limited dilution or immediate market impact from a volume perspective. The disclosure of a recent 410,000-share sale on 07/01/2025 shows the filer has already been active in the market. From a market-microstructure standpoint, impact depends on execution speed and order placement; the Form 144 itself merely documents intent and compliance with Rule 144.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing insider sales from vested RSUs/founder grants; governance disclosure appears complete.

The schedule of acquisition dates and grant types shows the shares proposed for sale were acquired primarily as RSUs or founder-share awards, with acquisition dates and amounts provided. The filer makes the standard representation of no undisclosed material adverse information and identifies the broker and planned sale date. There is no indication in the form of unusual trading arrangements, related-party transfers, or use of special exemptions. This is a routine governance disclosure required for insider liquidity; it does not, by itself, indicate corporate governance weakness.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	483750	4919737.50	65562670	08/25/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	12/20/2024	RSU	Issuer			43750	12/20/2024	N/A
Ordinary	09/22/2022	Founder shares / RSU	Issuer			48289	09/22/2022	N/A
Ordinary	10/06/2022	Founder shares / RSU	Issuer			82781	10/06/2022	N/A
Ordinary	06/22/2023	Founder shares / RSU	Issuer			48289	06/22/2023	N/A
Ordinary	12/22/2022	Founder shares / RSU	Issuer			48289	12/22/2022	N/A
Ordinary	03/22/2023	Founder shares / RSU	Issuer			48289	03/22/2023	N/A
Ordinary	10/02/2020	Founder shares / RSU	Issuer			82745	10/02/2020	N/A
Ordinary	01/01/2020	Founder shares / RSU	Issuer			121042	01/01/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ofer Druker 82 YIGAL ALON STREET 13TH FLOOR Tel-Aviv L3 6789124	Ordinary	07/01/2025	410000	4164685.56

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Nexxen's (NEXN) Form 144 announce?

The Form 144 notifies a proposed sale of 483,750 ordinary shares planned for 08/25/2025 through Oppenheimer & Co. Inc. with an aggregate market value of $4,919,737.50.

How large is the proposed sale relative to Nexxen's outstanding shares (NEXN)?

The issuer reports 65,562,670 shares outstanding, so the proposed sale of 483,750 shares is under 1% of outstanding shares.

What is the origin of the shares being sold under Rule 144?

The shares were acquired as RSUs and founder shares on multiple dates between 01/01/2020 and 12/20/2024, with individual lot sizes listed in the filing.

Has the filer sold shares recently?

Yes. The filing discloses a prior sale of 410,000 ordinary shares on 07/01/2025 for gross proceeds of $4,164,685.56.

Which broker is handling the planned sale for NEXN?

The broker named in the filing is Oppenheimer & Co. Inc., 85 Broad St., New York, NY 10004.